<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta name="viewport" content="width=device-width, initial-scale=1">

<style type="text/css">
@font-face {
font-family: octicons-link;
src: url(data:font/woff;charset=utf-8;base64,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) format('woff');
}
body {
-webkit-text-size-adjust: 100%;
text-size-adjust: 100%;
color: #333;
font-family: "Helvetica Neue", Helvetica, "Segoe UI", Arial, freesans, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol";
font-size: 16px;
line-height: 1.6;
word-wrap: break-word;
}
a {
background-color: transparent;
}
a:active,
a:hover {
outline: 0;
}
strong {
font-weight: bold;
}
h1 {
font-size: 2em;
margin: 0.67em 0;
}
img {
border: 0;
}
hr {
box-sizing: content-box;
height: 0;
}
pre {
overflow: auto;
}
code,
kbd,
pre {
font-family: monospace, monospace;
font-size: 1em;
}
input {
color: inherit;
font: inherit;
margin: 0;
}
html input[disabled] {
cursor: default;
}
input {
line-height: normal;
}
input[type="checkbox"] {
box-sizing: border-box;
padding: 0;
}
table {
border-collapse: collapse;
border-spacing: 0;
}
td,
th {
padding: 0;
}
* {
box-sizing: border-box;
}
input {
font: 13px / 1.4 Helvetica, arial, nimbussansl, liberationsans, freesans, clean, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol";
}
a {
color: #4078c0;
text-decoration: none;
}
a:hover,
a:active {
text-decoration: underline;
}
hr {
height: 0;
margin: 15px 0;
overflow: hidden;
background: transparent;
border: 0;
border-bottom: 1px solid #ddd;
}
hr:before {
display: table;
content: "";
}
hr:after {
display: table;
clear: both;
content: "";
}
h1,
h2,
h3,
h4,
h5,
h6 {
margin-top: 15px;
margin-bottom: 15px;
line-height: 1.1;
}
h1 {
font-size: 30px;
}
h2 {
font-size: 21px;
}
h3 {
font-size: 16px;
}
h4 {
font-size: 14px;
}
h5 {
font-size: 12px;
}
h6 {
font-size: 11px;
}
blockquote {
margin: 0;
}
ul,
ol {
padding: 0;
margin-top: 0;
margin-bottom: 0;
}
ol ol,
ul ol {
list-style-type: lower-roman;
}
ul ul ol,
ul ol ol,
ol ul ol,
ol ol ol {
list-style-type: lower-alpha;
}
dd {
margin-left: 0;
}
code {
font-family: Consolas, "Liberation Mono", Menlo, Courier, monospace;
font-size: 12px;
}
pre {
margin-top: 0;
margin-bottom: 0;
font: 12px Consolas, "Liberation Mono", Menlo, Courier, monospace;
}
.select::-ms-expand {
opacity: 0;
}
.octicon {
font: normal normal normal 16px/1 octicons-link;
display: inline-block;
text-decoration: none;
text-rendering: auto;
-webkit-font-smoothing: antialiased;
-moz-osx-font-smoothing: grayscale;
-webkit-user-select: none;
-moz-user-select: none;
-ms-user-select: none;
user-select: none;
}
.octicon-link:before {
content: '\f05c';
}
.markdown-body:before {
display: table;
content: "";
}
.markdown-body:after {
display: table;
clear: both;
content: "";
}
.markdown-body>*:first-child {
margin-top: 0 !important;
}
.markdown-body>*:last-child {
margin-bottom: 0 !important;
}
a:not([href]) {
color: inherit;
text-decoration: none;
}
.anchor {
display: inline-block;
padding-right: 2px;
margin-left: -18px;
}
.anchor:focus {
outline: none;
}
h1,
h2,
h3,
h4,
h5,
h6 {
margin-top: 1em;
margin-bottom: 16px;
font-weight: bold;
line-height: 1.4;
}
h1 .octicon-link,
h2 .octicon-link,
h3 .octicon-link,
h4 .octicon-link,
h5 .octicon-link,
h6 .octicon-link {
color: #000;
vertical-align: middle;
visibility: hidden;
}
h1:hover .anchor,
h2:hover .anchor,
h3:hover .anchor,
h4:hover .anchor,
h5:hover .anchor,
h6:hover .anchor {
text-decoration: none;
}
h1:hover .anchor .octicon-link,
h2:hover .anchor .octicon-link,
h3:hover .anchor .octicon-link,
h4:hover .anchor .octicon-link,
h5:hover .anchor .octicon-link,
h6:hover .anchor .octicon-link {
visibility: visible;
}
h1 {
padding-bottom: 0.3em;
font-size: 2.25em;
line-height: 1.2;
border-bottom: 1px solid #eee;
}
h1 .anchor {
line-height: 1;
}
h2 {
padding-bottom: 0.3em;
font-size: 1.75em;
line-height: 1.225;
border-bottom: 1px solid #eee;
}
h2 .anchor {
line-height: 1;
}
h3 {
font-size: 1.5em;
line-height: 1.43;
}
h3 .anchor {
line-height: 1.2;
}
h4 {
font-size: 1.25em;
}
h4 .anchor {
line-height: 1.2;
}
h5 {
font-size: 1em;
}
h5 .anchor {
line-height: 1.1;
}
h6 {
font-size: 1em;
color: #777;
}
h6 .anchor {
line-height: 1.1;
}
p,
blockquote,
ul,
ol,
dl,
table,
pre {
margin-top: 0;
margin-bottom: 16px;
}
hr {
height: 4px;
padding: 0;
margin: 16px 0;
background-color: #e7e7e7;
border: 0 none;
}
ul,
ol {
padding-left: 2em;
}
ul ul,
ul ol,
ol ol,
ol ul {
margin-top: 0;
margin-bottom: 0;
}
li>p {
margin-top: 16px;
}
dl {
padding: 0;
}
dl dt {
padding: 0;
margin-top: 16px;
font-size: 1em;
font-style: italic;
font-weight: bold;
}
dl dd {
padding: 0 16px;
margin-bottom: 16px;
}
blockquote {
padding: 0 15px;
color: #777;
border-left: 4px solid #ddd;
}
blockquote>:first-child {
margin-top: 0;
}
blockquote>:last-child {
margin-bottom: 0;
}
table {
display: block;
width: 100%;
overflow: auto;
word-break: normal;
word-break: keep-all;
}
table th {
font-weight: bold;
}
table th,
table td {
padding: 6px 13px;
border: 1px solid #ddd;
}
table tr {
background-color: #fff;
border-top: 1px solid #ccc;
}
table tr:nth-child(2n) {
background-color: #f8f8f8;
}
img {
max-width: 100%;
box-sizing: content-box;
background-color: #fff;
}
code {
padding: 0;
padding-top: 0.2em;
padding-bottom: 0.2em;
margin: 0;
font-size: 85%;
background-color: rgba(0,0,0,0.04);
border-radius: 3px;
}
code:before,
code:after {
letter-spacing: -0.2em;
content: "\00a0";
}
pre>code {
padding: 0;
margin: 0;
font-size: 100%;
word-break: normal;
white-space: pre;
background: transparent;
border: 0;
}
.highlight {
margin-bottom: 16px;
}
.highlight pre,
pre {
padding: 16px;
overflow: auto;
font-size: 85%;
line-height: 1.45;
background-color: #f7f7f7;
border-radius: 3px;
}
.highlight pre {
margin-bottom: 0;
word-break: normal;
}
pre {
word-wrap: normal;
}
pre code {
display: inline;
max-width: initial;
padding: 0;
margin: 0;
overflow: initial;
line-height: inherit;
word-wrap: normal;
background-color: transparent;
border: 0;
}
pre code:before,
pre code:after {
content: normal;
}
kbd {
display: inline-block;
padding: 3px 5px;
font-size: 11px;
line-height: 10px;
color: #555;
vertical-align: middle;
background-color: #fcfcfc;
border: solid 1px #ccc;
border-bottom-color: #bbb;
border-radius: 3px;
box-shadow: inset 0 -1px 0 #bbb;
}
.pl-c {
color: #969896;
}
.pl-c1,
.pl-s .pl-v {
color: #0086b3;
}
.pl-e,
.pl-en {
color: #795da3;
}
.pl-s .pl-s1,
.pl-smi {
color: #333;
}
.pl-ent {
color: #63a35c;
}
.pl-k {
color: #a71d5d;
}
.pl-pds,
.pl-s,
.pl-s .pl-pse .pl-s1,
.pl-sr,
.pl-sr .pl-cce,
.pl-sr .pl-sra,
.pl-sr .pl-sre {
color: #183691;
}
.pl-v {
color: #ed6a43;
}
.pl-id {
color: #b52a1d;
}
.pl-ii {
background-color: #b52a1d;
color: #f8f8f8;
}
.pl-sr .pl-cce {
color: #63a35c;
font-weight: bold;
}
.pl-ml {
color: #693a17;
}
.pl-mh,
.pl-mh .pl-en,
.pl-ms {
color: #1d3e81;
font-weight: bold;
}
.pl-mq {
color: #008080;
}
.pl-mi {
color: #333;
font-style: italic;
}
.pl-mb {
color: #333;
font-weight: bold;
}
.pl-md {
background-color: #ffecec;
color: #bd2c00;
}
.pl-mi1 {
background-color: #eaffea;
color: #55a532;
}
.pl-mdr {
color: #795da3;
font-weight: bold;
}
.pl-mo {
color: #1d3e81;
}
kbd {
display: inline-block;
padding: 3px 5px;
font: 11px Consolas, "Liberation Mono", Menlo, Courier, monospace;
line-height: 10px;
color: #555;
vertical-align: middle;
background-color: #fcfcfc;
border: solid 1px #ccc;
border-bottom-color: #bbb;
border-radius: 3px;
box-shadow: inset 0 -1px 0 #bbb;
}
.task-list-item {
list-style-type: none;
}
.task-list-item+.task-list-item {
margin-top: 3px;
}
.task-list-item input {
margin: 0 0.35em 0.25em -1.6em;
vertical-align: middle;
}
:checked+.radio-label {
z-index: 1;
position: relative;
border-color: #4078c0;
}
.sourceLine {
display: inline-block;
}
code .kw { color: #000000; }
code .dt { color: #ed6a43; }
code .dv { color: #009999; }
code .bn { color: #009999; }
code .fl { color: #009999; }
code .ch { color: #009999; }
code .st { color: #183691; }
code .co { color: #969896; }
code .ot { color: #0086b3; }
code .al { color: #a61717; }
code .fu { color: #63a35c; }
code .er { color: #a61717; background-color: #e3d2d2; }
code .wa { color: #000000; }
code .cn { color: #008080; }
code .sc { color: #008080; }
code .vs { color: #183691; }
code .ss { color: #183691; }
code .im { color: #000000; }
code .va {color: #008080; }
code .cf { color: #000000; }
code .op { color: #000000; }
code .bu { color: #000000; }
code .ex { color: #000000; }
code .pp { color: #999999; }
code .at { color: #008080; }
code .do { color: #969896; }
code .an { color: #008080; }
code .cv { color: #008080; }
code .in { color: #008080; }
</style>
<style>
body {
  box-sizing: border-box;
  min-width: 200px;
  max-width: 980px;
  margin: 0 auto;
  padding: 45px;
  padding-top: 0px;
}
</style>

</head>

<body>

<h1 id="gda-exam-2021">GDA Exam 2021</h1>
<p>Giulio Caravagna (<a href="mailto:gcaravagna@units.it">gcaravagna@units.it</a>) 5/14/2021</p>
<h1 id="group-final-project">Group final project</h1>
<p>You will carry out a multi-step analysis of <strong>bulk WGS</strong> data, using the tools that we have seen during the lectures. The aim is to determine subgroups of patients (i.e., clusters) of similar evolutionary trajectories, if they exist in the data. The ones that are most important are prognostic (i.e., associate with survival analysis).</p>
<p>You need to implement the steps discussed below, assuming to work with data from one PCAWG tumour type (e.g., colon). Ideally, you should analyse multiple, if not all, tumour types.</p>
<h3 id="what-data-you-will-work-with">What data you will work with</h3>
<p>You will be given an extended version of PCAWG data, with one <code>rds</code> file per patient formatted in the usual way. The cohort metadata is available as a <a href="https://www.dropbox.com/s/97fqh6lt0g8qf5f/pcawg_icgc_cohort.csv?dl=0">CSV file</a>.</p>
<p>In these data we provide you with <em>somatic driver annotations</em> derived from simple somatic mutations (SNVs); this type of information was not available in the batch we shared during lectures. Drivers are annotated as two extra columns in the data matrix, <code>is_driver</code> and <code>driver_label</code>, which are <code>TRUE</code> if the event is a putative driver.</p>
<p>In one step of the analysis, you will have to augment a little bit this drivers list.</p>
<h3 id="quality-control-somatic-calls">Quality control somatic calls</h3>
<p>The aim is to identify <em>reasonable criteria</em> to determine what samples should be forwarded for downstream analysis, using the available QC scores or any other (automated) criterion you want to create from a CNAqc analysis.</p>
<p>For instance, you could use hard cutoffs on CNAqc analysis (e.g., take the QC statuses by the tool), or perform some more complicated decision task using some form of classifier. A possibility is a logistic classifier, which you would supervise annotating <code>PASS</code>/<code>FAIL</code> status by manual assessment of some hundred cases, that determines cuts for inclusion based on covariates such as tumour purity, average coverage, coverage per karyptype, mutations per karyotype, etc.</p>
<p>For this part of the analysis, you should prepare to show some <code>PASS</code> and <code>FAIL</code> cases to motivate your criteria.</p>
<h3 id="perform-tumour-subclonal-deconvolution">Perform tumour subclonal deconvolution</h3>
<p>We want to perform a CCF-based deconvolution using MOBSTER, and determine which clusters will be used for the next analysis.</p>
<p>CCF values can be computed from CNAqc, following the steps of <a href="https://caravagnalab.github.io/CNAqc/articles/a4_ccf_computation.html">this vignette</a>. You should take a decision about what karyotypes you will use, based on the previous QC step (e.g., a <code>FAIL</code> karyotype might be removed). The CNAqc CCF computation will also return a <code>PASS</code> or <code>FAIL</code> status per karyotype, you should take a decision also based on this QC-metric.</p>
<p>Once you have selected CCF values that you consider reliable, you can fit them with MOBSTER. To do that, you need to add a <code>VAF</code> column to your data - there is one already - and put the CCF values in there. The deconvolution can select only mutations with VAF above a cutoff (e.g., <code>0.05</code>), and set <code>auto_setup = &quot;FAST&quot;</code> in <a href="https://caravagnalab.github.io/mobster/reference/mobster_fit.html">mobster_fit</a> to get faster runs.</p>
<p>Investigate critically the quality of the fits obtained by your analysis. From every fit, you should flag tail mutations and determine the growth parameters of the tumour. Tail mutations can be determined from clustering assignments using <a href="https://caravagnalab.github.io/mobster/reference/Clusters.html">Clusters</a> function from MOBSTER. The evolutionary parameters are computed by function <a href="https://caravagnalab.github.io/mobster/reference/evolutionary_parameters.html">evolutionary_parameters</a>, also in MOBSTER. Measure the mutation rate <em>μ</em> for the whole biopsy and the selection coefficient <em>s</em> or the age <em>t</em> for each Beta subclone in MOBSTER - recall that <code>C2</code>, <code>C3</code>, …, are subclonal, while <code>C1</code> is clonal.</p>
<h3 id="cluster-evolutionary-trajectories">Cluster evolutionary trajectories</h3>
<p>Here we want to compute evolutionary subgroups in the cancer type selected, and determine if they have significant survival probability using PCAWG clinical data (where available).</p>
<p>From non-tail mutations, you can prepare <a href="https://caravagnalab.github.io/revolver/articles/Input_formats.html">REVOLVER inputs</a>_. In this case call the biopsy <code>Primary</code> to format the <code>CCF</code> string, e.g., <code>Primary:.54</code> is a 54% VAF in the sample. For each mutation, use the CCF of its MOBSTER cluster (Beta mean), instead of the mutation’s own CCF.</p>
<p>To run REVOLVER we need to consolidate driver annotations. In particular, we want to distinguish between <em>tumour suppressor genes</em>, and <em>oncogenes</em>. A list of the roles for each possible gene is accessible as Tier-1 data from the <a href="https://cancer.sanger.ac.uk/census">Cancer Gene Census (CGC)</a>, scrolling to the end of the page and downloading the TSV table. Note that some of the drivers you might find already annotated in the PCAWG data are not present in the CGC, or not have a suppressor/oncogene status associated. For those, you should do nothing (just keep them as they are).</p>
<p>For suppressors, instead, you want to check if the gene, besides the mutation present in the data, harbours <em>also</em> an LOH in the segment where the gene maps. If it does, the <code>driver_label</code> in the data should distinguish suppressors with just a mutation (e.g., <code>TP53 mut</code>), from those with complete inactivation (mutation plus LOH, e.g., <code>TP53 inactive</code>). In order to map genes to copy number segment you can use geen coordinates available in <a href="https://github.com/Militeee/rcongas/blob/master/data/hg19_gene_coordinates.rda">this tibble</a>.</p>
<p>For oncogenes, instead, you want to check if the gene has mutations and <em>sits on top</em> of an amplified copy number segment (<code>2:1</code> or <code>2:2</code>). This information is implicitly available from CCF computation: every oncogene with mutation multiplicity <em>m</em> &gt; 1 is on the amplified chromosome segment. Split your oncogenes as just mutated (e.g., <code>PIK3CA mut</code>), or mutation and amplified, e.g., <code>PIK3CA mutamp</code>.</p>
<p>An important result of this selection step is that you will be losing many drivers if they map in segments that are not supported by CNAqc. Try to keep track of that information and reason critically on the part of signal that you are missing by considering only karyotypes <code>1:0</code>, <code>1:1</code>, <code>2:0</code>, <code>2:1</code> and <code>2:2</code>.</p>
<p>You can run REVOLVER with default parameters, following the <a href="https://github.com/caravagn/revolver.misc/blob/master/vignette_TRACERx_Hanjani_et_al/vignette_TRACERx_Hanjani_et_al.md">TRACERx vignette</a>. You will apply cohort-level frequency filters set up to retain enough driver events (% in the cohort), which you need to correlate trajectories with REVOLVER. Exclude the bootstrap from your analysis, or leave that as an option to compute at a later stage.</p>
<h3 id="perform-surival-analysis">Perform surival analysis</h3>
<p>Here we want to test if some of the groups show distinct trends of survival, using standard methods (Kaplan-Meier curves etc.) available in R.</p>
<p>You will perform survival analysis between pairs of REVOLVER clusters, and across all clusters. To do that, you will need <a href="https://dcc.icgc.org/api/v1/download?fn=/PCAWG/clinical_and_histology/pcawg_donor_clinical_August2016_v9.xlsx">clinical data</a> from PCAWG.</p>
<p>You might miss some patients where the data are not available in the 2018 release batch; try to see if the more updated <a href="https://dcc.icgc.org/">repository</a> has more recent data. To query the web portal, you will need to convert the 16 digits sample id to the ICGC one, using columns <code>icgc_donor_id</code> and <code>aliquot_id</code> in the cohort metadata table. In general, you might have that for some groups you have little surival data to use.</p>
<p>Survival analysis can be done following <a href="https://github.com/caravagn/revolver.misc/blob/master/vignette_survival_Breast_Yates_et_al/vignette_survival_Breast_Yates_et_al.md">this vignette</a>. Use <code>donor_survival_time</code> (number) and <code>donor_vital_status</code> (categorical) to predict survival.</p>
<h1 id="assessment">Assessment</h1>
<p>The project can be carried out in groups of one or more students. Each of you must have a distinct role defined from the very beginning.</p>
<p>You can divide the tasks among the team, or participate all together in every task (srrange this the way you prefer). You will be mentored for all the project (weekly), where each one of you will have to present his progress and discuss doubts and technical issues, where they raised.</p>
<p>You should work like a team, organise a GitHub repository and create reports of your results (images, tables with statistics etc.). In the end, you will be giving a presentation, with slides, about your most salient results. Try to look critically to your data and the analysis you are carrying out.</p>

</body>
</html>
